{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:35:24Z","timestamp":1780504524139,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:00:00Z","timestamp":1719619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Public Assistance Hospitals Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021716","name":"University Paris Cit\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.placenta.2024.06.019","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T06:42:09Z","timestamp":1719643329000},"page":"122-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: A cross-sectional study"],"prefix":"10.1016","volume":"154","author":[{"given":"Clothilde","family":"Gros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Mageau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Barral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale Roland","family":"Nicaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Saint-Frison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margot","family":"Bucau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Vivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine Marie","family":"Ferre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Bourgeois-Moine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Papo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Goulenok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-234X","authenticated-orcid":false,"given":"Karim","family":"Sacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2024.06.019_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.placenta.2024.06.019_bib2","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients: clinical and Immunologic Manifestations of APS","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.placenta.2024.06.019_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13075-018-1745-2","article-title":"Intrauterine fetal deaths related to antiphospholipid syndrome: a descriptive study of 65 women","volume":"20","author":"Belhocine","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.placenta.2024.06.019_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13075-021-02518-7","article-title":"Evaluation of the severe preeclampsia classification criterion for antiphospholipid syndrome in a study of 40 patients","volume":"23","author":"Larosa","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.placenta.2024.06.019_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.thromres.2023.05.014","article-title":"Unexplained fetal death, pre-eclampsia and fetal growth restriction in pregnancy: who is screened for antiphospholipid syndrome?","volume":"228","author":"Gros","year":"2023","journal-title":"Thromb. Res."},{"key":"10.1016\/j.placenta.2024.06.019_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.semarthrit.2016.05.006","article-title":"Non-conventional antiphospholipid antibodies in patients with clinical obstetrical APS: prevalence and treatment efficacy in pregnancies","volume":"46","author":"Mekinian","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.placenta.2024.06.019_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001340","article-title":"Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study","volume":"6","author":"Abisror","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/j.placenta.2024.06.019_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/0961203319826358","article-title":"\u2018Seronegative antiphospholipid syndrome\u2019: an update","volume":"28","author":"Hughes","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.placenta.2024.06.019_bib9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.placenta.2024.06.019_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/annrheumdis-2011-200614","article-title":"Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called \u2018seronegative APS\u2019)","volume":"71","author":"Rodriguez-Garcia","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.placenta.2024.06.019_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0037-1614001","article-title":"Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The N\u00eemes Obstetricians and Haematologists Study--NOHA","volume":"84","author":"Gris","year":"2000","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.placenta.2024.06.019_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1600-0897.2011.01008.x","article-title":"A unique preliminary study on placental apoptosis in mice with passive immunization of anti-phosphatidylethanolamine antibodies and anti-factor XII antibodies","volume":"66","author":"Velayuthaprabhu","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2024.06.019_bib13","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/rheumatology\/ket126","article-title":"Seronegative antiphospholipid syndrome","volume":"52","author":"Nayfe","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.placenta.2024.06.019_bib14","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ajog.2015.08.041","article-title":"Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.06.019_bib15","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/art.40136","article-title":"Emerging treatment models in rheumatology: antiphospholipid syndrome and pregnancy: pathogenesis to translation","volume":"69","author":"Abrahams","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.placenta.2024.06.019_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/humupd\/dmu049","article-title":"Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment","volume":"21","author":"Tong","year":"2015","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.placenta.2024.06.019_bib17","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/rheumatology\/keaa499","article-title":"Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies","volume":"60","author":"Spinillo","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.placenta.2024.06.019_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/096120339800700218","article-title":"Placental pathology in antiphospholipid syndrome","volume":"7","author":"Levy","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.placenta.2024.06.019_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.placenta.2003.12.006","article-title":"Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes","volume":"25","author":"Van Horn","year":"2004","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2024.06.019_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.placenta.2005.04.006","article-title":"The placental bed in pregnancies complicated by primary antiphospholipid syndrome","volume":"27","author":"Stone","year":"2006","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2024.06.019_bib21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.autrev.2015.01.008","article-title":"Histopathology in the placentae of women with antiphospholipid antibodies: a systematic review of the literature","volume":"14","author":"Viall","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.placenta.2024.06.019_bib22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.placenta.2024.06.019_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","article-title":"Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT","volume":"197","author":"van Hoorn","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.placenta.2024.06.019_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000131","article-title":"Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results","volume":"3","author":"Yelnik","year":"2016","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.placenta.2024.06.019_bib25","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.34402","article-title":"Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies","volume":"64","author":"Lockshin","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.placenta.2024.06.019_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12026-013-8421-z","article-title":"Anti-phosphatidylserine\/prothrombin antibodies: an additional diagnostic marker for APS?","volume":"56","author":"Pregnolato","year":"2013","journal-title":"Immunol. Res."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424002947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424002947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T00:36:58Z","timestamp":1728261418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400424002947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":26,"alternative-id":["S0143400424002947"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2024.06.019","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2024.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}